{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:59:43Z","timestamp":1784696383766,"version":"3.55.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.wneu.2021.07.104","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T12:55:11Z","timestamp":1627649711000},"page":"41-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effects of Various Therapeutic Agents on Vasospasm and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage\u2013Results of a Network Meta-Analysis"],"prefix":"10.1016","volume":"155","author":[{"given":"Sandeep","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwaljeet","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwa Bharathi","family":"Gaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preet Mohinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmohan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Sarat","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank Sharad","family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2021.07.104_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0140-6736(16)30668-7","article-title":"Spontaneous subarachnoid haemorrhage","volume":"389","author":"Macdonald","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.wneu.2021.07.104_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00003643-199801001-00047","article-title":"Epidemiology of subarachnoid haemorrhage","volume":"15","author":"Monstrey","year":"1998","journal-title":"Eur J Anaesthesiol EJA"},{"key":"10.1016\/j.wneu.2021.07.104_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/cc5958","article-title":"Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage","volume":"11","author":"Keyrouz","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2021.07.104_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM198303173081103","article-title":"Cerebral arterial spasm\u2013a controlled trial of nimodipine in patients with subarachnoid hemorrhage","volume":"308","author":"Allen","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2021.07.104_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.STR.0000254601.74596.0f","article-title":"Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study","volume":"38","author":"Barth","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib6","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.18632\/aging.102788","article-title":"Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults","volume":"12","author":"Chen","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.wneu.2021.07.104_bib7","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1161\/STROKEAHA.107.505875","article-title":"A\u00a0randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage","volume":"39","author":"Chou Sherry","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12028-015-0233-7","article-title":"Effect of high-dose simvastatin on cerebral blood flow and static autoregulation in subarachnoid hemorrhage","volume":"25","author":"Diringer","year":"2016","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.wneu.2021.07.104_bib9","first-page":"593","article-title":"Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study","volume":"49","author":"Egge","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2021.07.104_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/02688697.2012.757293","article-title":"Role of simvastatin in prevention of vasospasm and improving functional outcome after aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled pilot trial","volume":"27","author":"Garg","year":"2013","journal-title":"Br J Neurosurg"},{"issue":"suppl 2","key":"10.1016\/j.wneu.2021.07.104_bib11","doi-asserted-by":"crossref","first-page":"P112","DOI":"10.1186\/cc6333","article-title":"Impact of treatment with pravastatin on delayed ischemic disease and mortality after aneurysmal subarachnoid hemorrhage","volume":"12","author":"Jaschinski","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2021.07.104_bib12","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1474-4422(14)70084-5","article-title":"Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial","volume":"13","author":"Kirkpatrick","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2021.07.104_bib13","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1161\/01.STR.0000177879.11607.10","article-title":"Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial","volume":"36","author":"Lynch","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib14","series-title":"Early Brain Injury or Cerebral Vasospasm. Acta Neurochirurgica Supplements","first-page":"17","article-title":"Effect of a free radical scavenger, edaravone, on free radical reactions: related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model","author":"Munakata","year":"2011"},{"key":"10.1016\/j.wneu.2021.07.104_bib15","first-page":"792","article-title":"Effects of a hydroxyl radical scavenger on DINDs following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial","volume":"84","author":"Asano","year":"1996","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00701-007-1249-3","article-title":"Effects of the selective endothelin A (ET(A)) receptor antagonist clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series","volume":"149","author":"Barth","year":"2007","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2021.07.104_bib17","first-page":"467","article-title":"A\u00a0randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America","volume":"86","author":"Haley","year":"1997","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.surneu.2007.07.015","article-title":"Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial","volume":"69","author":"Muroi","year":"2008","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2021.07.104_bib19","first-page":"992","article-title":"Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK\/Netherlands\/Eire TAK-044 Subarachnoid Haemorrhage Study Group","volume":"93","author":"Shaw","year":"2000","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib20","first-page":"571","article-title":"Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: results of a prospective placebo-controlled double-blind trial","volume":"76","author":"Shibuya","year":"1992","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib21","first-page":"953","article-title":"No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial","volume":"99","author":"Siironen","year":"2003","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/01616412.1989.11739867","article-title":"Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study","volume":"11","author":"Suzuki","year":"1989","journal-title":"Neurol Res"},{"key":"10.1016\/j.wneu.2021.07.104_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2176\/nmc.46.421","article-title":"Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage","volume":"46","author":"Zhao","year":"2006","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2021.07.104_bib24","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.wneu.2019.07.016","article-title":"Efficacy of statins in cerebral vasospasm, mortality, and delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of randomized controlled trials","volume":"131","author":"Shen","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.wneu.2021.02.069","article-title":"Role of cilostazol in prevention of vasospasm after aneurysmal subarachnoid hemorrhage\u2013a systematic review, meta-analysis, and trial sequential analysis","volume":"150","author":"Bohara","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.wneu.2019.01.103","article-title":"Intracranial administration of nicardipine after aneurysmal subarachnoid hemorrhage: a review of the literature","volume":"125","author":"Dodson","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib27","doi-asserted-by":"crossref","first-page":"620096","DOI":"10.3389\/fneur.2021.620096","article-title":"Statins improve clinical outcome after non-aneurysmal subarachnoid hemorrhage: a translational insight from a systematic review of experimental studies","volume":"12","author":"Kashefiolasl","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.wneu.2021.07.104_bib28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/ACO.0000000000000370","article-title":"Cerebral vasospasm: current understanding","volume":"29","author":"Rao","year":"2016","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.wneu.2021.07.104_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analysis of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.wneu.2021.07.104_bib30","first-page":"1092","article-title":"Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial","volume":"107","author":"Tseng","year":"2007","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib31","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jocn.2009.01.011","article-title":"The prediction of long-term outcome after subarachnoid hemorrhage as measured by the Short Form-36 Health Survey","volume":"16","author":"Scharbrodt","year":"2009","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2021.07.104_bib32","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/STROKEAHA.111.648980","article-title":"Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling","volume":"43","author":"Macdonald","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib33","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/jcbfm.2009.59","article-title":"Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial","volume":"29","author":"Vergouwen","year":"2009","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.wneu.2021.07.104_bib34","first-page":"9","article-title":"Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study","volume":"103","author":"Vajkoczy","year":"2005","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00008506-200604000-00009","article-title":"Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study","volume":"18","author":"Wong","year":"2006","journal-title":"J\u00a0Neurosurg Anesthesiol"},{"key":"10.1016\/j.wneu.2021.07.104_bib36","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/01.STR.0000176743.67564.5d","article-title":"Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial","volume":"36","author":"Tseng","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib37","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A\u00a0GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.wneu.2021.07.104_bib38","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/01.STR.0000160801.96998.57","article-title":"Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial","volume":"36","author":"van den Bergh","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000475824","article-title":"Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients","volume":"44","author":"Fujimura","year":"2017","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.wneu.2021.07.104_bib40","first-page":"537","article-title":"A\u00a0randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study","volume":"78","author":"Haley","year":"1993","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib41","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1161\/01.STR.0000094731.63690.FF","article-title":"Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study","volume":"34","author":"Hamada","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1227\/00006123-198808000-00004","article-title":"Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms","volume":"23","author":"Jan","year":"1988","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2021.07.104_bib43","first-page":"221","article-title":"Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand","volume":"84","author":"Kassell","year":"1996","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib44","first-page":"1018","article-title":"Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America","volume":"90","author":"Lanzino","year":"1999","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/01.STR.31.2.383","article-title":"Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage\u00a0: a randomized controlled trial","volume":"31","author":"Lennihan","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib46","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1161\/STROKEAHA.108.519942","article-title":"Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1)","volume":"39","author":"Loch","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib47","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","volume":"10","author":"Macdonald","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2021.07.104_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000445509","article-title":"Effect of cilostazol on cerebral vasospasm and outcome in patients with aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Matsuda","year":"2016","journal-title":"Cerebrovasc Dis Basel Switz"},{"key":"10.1016\/j.wneu.2021.07.104_bib49","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1227\/00006123-198803000-00006","article-title":"Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage","volume":"22","author":"Mee","year":"1988","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2021.07.104_bib50","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1227\/00006123-198704000-00007","article-title":"Prediction and prevention of delayed ischemic dysfunction after aneurysmal subarachnoid hemorrhage and early operation","volume":"20","author":"Messeter","year":"1987","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2021.07.104_bib51","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/0271678X17724682","article-title":"Long-acting statin for aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Naraoka","year":"2018","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"issue":"suppl K","key":"10.1016\/j.wneu.2021.07.104_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/8.suppl_K.41","article-title":"Early intervention with nimodipine in subarachnoid haemorrhage","volume":"8","author":"Neil-Dwyer","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1016\/j.wneu.2021.07.104_bib53","first-page":"683","article-title":"Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery","volume":"69","author":"Ohman","year":"1988","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib54","first-page":"8","article-title":"Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery","volume":"74","author":"Ohman","year":"1991","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib55","first-page":"505","article-title":"Nimodipine treatment in poor-grade aneurysm patients: results of a multicenter double-blind placebo-controlled trial","volume":"68","author":"Petruk","year":"1988","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF01456369","article-title":"Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine","volume":"82","author":"Philippon","year":"1986","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2021.07.104_bib57","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","article-title":"Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial","volume":"298","author":"Pickard","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.wneu.2021.07.104_bib58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00006123-199802000-00038","article-title":"Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage","volume":"42","author":"Saito","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2021.07.104_bib59","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1227\/01.NEU.0000215868.40441.D9","article-title":"Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study","volume":"58","author":"Schmid-Elsaesser","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2021.07.104_bib60","first-page":"121","article-title":"Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial: clinical article","volume":"118","author":"Senbokuya","year":"2013","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib61","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00701-007-1284-z","article-title":"Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial","volume":"149","author":"Springborg","year":"2007","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2021.07.104_bib62","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.25361","article-title":"Cilostazol decreases duration of spreading depolarization and spreading ischemia after aneurysmal subarachnoid hemorrhage","volume":"84","author":"Sugimoto","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.wneu.2021.07.104_bib63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000327040","article-title":"Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report","volume":"32","author":"Suzuki","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.wneu.2021.07.104_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01402177","article-title":"Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study","volume":"102","author":"Tsementzis","year":"1990","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2021.07.104_bib65","first-page":"510","article-title":"Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage","volume":"96","author":"Veyna","year":"2002","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib66","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/CCM.0b013e3181d9da1e","article-title":"Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study","volume":"38","author":"Westermaier","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.wneu.2021.07.104_bib67","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/STROKEAHA.114.007006","article-title":"High-dose simvastatin for aneurysmal subarachnoid hemorrhage","volume":"46","author":"Wong George","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clineuro.2004.01.006","article-title":"Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo","volume":"106","author":"Wurm","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib69","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1213\/ANE.0000000000000892","article-title":"Systematic reviews of anesthesiologic interventions reported as statistically significant: problems with power, precision, and type 1 error protection","volume":"121","author":"Imberger","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1016\/j.wneu.2021.07.104_bib70","doi-asserted-by":"crossref","first-page":"e011890","DOI":"10.1136\/bmjopen-2016-011890","article-title":"False-positive findings in Cochrane meta-analysis with and without application of trial sequential analysis: an empirical review","volume":"6","author":"Imberger","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.wneu.2021.07.104_bib71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1227\/00006123-198308000-00018","article-title":"Role of multiple cerebral microthrombosis in symptomatic cerebral vasospasm: with a case report","volume":"13","author":"Suzuki","year":"1983","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2021.07.104_bib72","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1793-5482.85632","article-title":"Role of magnesium sulfate in aneurysmal subarachnoid hemorrhage management: a meta-analysis of controlled clinical trials","volume":"6","author":"Chen","year":"2011","journal-title":"Asian J Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/00006123-198001000-00001","article-title":"Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning","volume":"6","author":"Fisher","year":"1980","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2021.07.104_bib74","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/STROKEAHA.110.597005","article-title":"Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage","volume":"42","author":"Crowley","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib75","first-page":"255","article-title":"Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage","volume":"101","author":"Reilly","year":"2004","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib76","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/STROKEAHA.112.674291","article-title":"Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors","volume":"44","author":"de Rooij","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib77","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1016\/j.wneu.2020.01.026","article-title":"Upregulation of connexin 40 mediated by nitric oxide attenuates cerebral vasospasm after subarachnoid hemorrhage via the nitric oxide-cyclic guanosine monophosphate-protein kinase G pathway","volume":"136","author":"Lan","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib78","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.wneu.2019.08.119","article-title":"Effect of L-arginine therapy on vasospasm: experimental study in rats","volume":"132","author":"Akar","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib79","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1016\/j.wneu.2019.08.001","article-title":"Does nimodipine interruption due to high catecholamine doses lead to a greater incidence of delayed cerebral ischemia in the setting of aneurysmal subarachnoid hemorrhage?","volume":"132","author":"Hern\u00e1ndez-Dur\u00e1n","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib80","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.wneu.2020.05.075","article-title":"Increased risk of transient cerebral ischemia after subarachnoid hemorrhage in patients with premorbid opioid use disorders: a nationwide analysis of outcomes","volume":"141","author":"Martini","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib81","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/j.wneu.2021.03.031","article-title":"Predictive relevance of early temperature elevation on the risk of delayed cerebral ischemia development following aneurysmal subarachnoid hemorrhage","volume":"150","author":"Saripalli","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib82","doi-asserted-by":"crossref","first-page":"e942","DOI":"10.1016\/j.wneu.2021.01.070","article-title":"Relationship between brain tissue oxygen tension and transcranial Doppler ultrasonography","volume":"149","author":"Craven","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib83","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1016\/j.wneu.2020.12.102","article-title":"Aggressive intraoperative cisternal clot removal after clipping aneurismal subarachnoid hemorrhage in elderly patients","volume":"147","author":"Yoshikane","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib84","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.wneu.2020.12.064","article-title":"Effect of surgical arachnoid plasty on functional outcome in aneurysmal subarachnoid hemorrhage","volume":"147","author":"Katagai","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib85","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/j.wneu.2020.09.099","article-title":"Bibliometric analysis of the top 100 most cited articles on cerebral vasospasm","volume":"145","author":"Elarjani","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib86","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.wneu.2020.10.008","article-title":"Risk factors for cerebral vasospasm in aneurysmal subarachnoid hemorrhage: a population-based study of 8346 patients","volume":"145","author":"Rumalla","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib87","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.wneu.2020.09.078","article-title":"Rapid evolution and rupture of an incidental aneurysm during hyperdynamic therapy for cerebral vasospasm","volume":"145","author":"Chagoya","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib88","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1016\/j.wneu.2020.09.042","article-title":"Body mass index and overall outcome following subarachnoid hemorrhage: an obesity paradox?","volume":"144","author":"Damodara","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib89","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/j.wneu.2020.07.186","article-title":"Effects of lutein on brain damage and vasospasm in an experimental subarachnoid hemorrhage model","volume":"143","author":"Turk","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib90","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1016\/j.wneu.2020.05.230","article-title":"Amelioration of cerebral vasospasm and secondary injury by vigabatrin after experimental subarachnoid hemorrhage in the rabbit","volume":"141","author":"Fesli","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib91","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nec.2017.09.003","article-title":"Imaging evaluation of degenerative cervical myelopathy: current state of the art and future directions","volume":"29","author":"Martin","year":"2018","journal-title":"Neurosurg Clin North Am"},{"key":"10.1016\/j.wneu.2021.07.104_bib92","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/j.wneu.2020.03.151","article-title":"Blocking VEGF by bevacizumab attenuates VEGF-induced vasospasm after experimental subarachnoid hemorrhage in rabbits","volume":"139","author":"Akturk","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib93","doi-asserted-by":"crossref","first-page":"e913","DOI":"10.1016\/j.wneu.2020.03.146","article-title":"Cerebral vasospasm after spontaneous subarachnoid hemorrhage: angiographic pattern and its impact on the clinical course","volume":"138","author":"Ditz","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib94","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1016\/j.wneu.2020.03.087","article-title":"Discrepancy in neurologic outcomes following aneurysmal subarachnoid hemorrhage as a function of socioeconomic class","volume":"138","author":"Strickland","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib95","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1016\/j.wneu.2020.03.058","article-title":"The impact of propolis factor caffeic acid phenethyl-ester on the cerebral vasospasm and early brain damage in the experimentally induced subarachnoid hemorrhage on rats","volume":"138","author":"Palaz","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib96","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1016\/j.wneu.2019.12.097","article-title":"Novel treatment of cerebral vasospasm using Solitaire stent retriever-assisted angioplasty: case series","volume":"135","author":"Su","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib97","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/01.STR.0000014563.75483.22","article-title":"Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans","volume":"33","author":"Kasuya","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib98","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/01616412.2000.11740733","article-title":"Prevention of cerebral vasospasm by nicardipine prolonged-release implants in dogs","volume":"22","author":"Kawashima","year":"2000","journal-title":"Neurol Res"},{"key":"10.1016\/j.wneu.2021.07.104_bib99","first-page":"955","article-title":"Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipine prolonged-release implants","volume":"110","author":"Barth","year":"2009","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-7091-1192-5_9","article-title":"Development of nicardipine prolonged-release implants after clipping for preventing cerebral vasospasm: from laboratory to clinical trial","volume":"115","author":"Kasuya","year":"2013","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.wneu.2021.07.104_bib101","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2176\/nmc.47.389","article-title":"Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first 100 patients","volume":"47","author":"Krischek","year":"2007","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2021.07.104_bib102","doi-asserted-by":"crossref","first-page":"394","DOI":"10.25259\/SNI_640_2020","article-title":"Complete relief of vasospasm\u2013effect of nicardipine coating during direct clipping for the patient with symptomatic vasospasm of subarachnoid hemorrhage","volume":"11","author":"Yokoya","year":"2020","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.wneu.2021.07.104_bib103","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/STROKEAHA.110.579383","article-title":"Endovascular treatment or neurosurgical clipping of ruptured intracranial aneurysms","volume":"41","author":"Dumont","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.07.104_bib104","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1016\/j.wneu.2013.08.017","article-title":"Treatment modality and vasospasm after aneurysmal subarachnoid hemorrhage","volume":"82","author":"Gross","year":"2014","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1227\/NEU.0b013e31822e5a8e","article-title":"Method of aneurysm treatment does not affect clot clearance after aneurysmal subarachnoid hemorrhage","volume":"70","author":"Ibrahim","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2021.07.104_bib106","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10143-006-0045-5","article-title":"Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"30","author":"de Oliveira","year":"2007","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.wneu.2021.07.104_bib107","first-page":"1967","article-title":"Outcome of oral and intra-arterial nimodipine administration after aneurysmal subarachnoid haemorrhage\u2013a single-centre study","volume":"33","author":"Ehrlich","year":"2019","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.wneu.2021.07.104_bib108","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5935\/0103-507X.20200097","article-title":"Efficacy and safety of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage: a systematic review","volume":"32","author":"Santos-Teles","year":"2020","journal-title":"Rev Bras Ter Intensiva"},{"key":"10.1016\/j.wneu.2021.07.104_bib109","doi-asserted-by":"crossref","first-page":"106546","DOI":"10.1016\/j.clineuro.2021.106546","article-title":"The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"202","author":"Mao","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib110","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.wneu.2017.02.014","article-title":"Effect of intra-arterial and intravenous nimodipine therapy of cerebral vasospasm after subarachnoid hemorrhage on cerebrovascular reactivity and oxygenation","volume":"101","author":"Hockel","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.104_bib111","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-3-030-04615-6_28","article-title":"Intra-arterial administration of verapamil for the prevention and treatment of cerebral angiospasm","volume":"127","author":"Mikeladze","year":"2020","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.wneu.2021.07.104_bib112","doi-asserted-by":"crossref","first-page":"18780","DOI":"10.1038\/s41598-020-75365-2","article-title":"Computational methods for visualizing and measuring verapamil efficacy for cerebral vasospasm","volume":"10","author":"Abumoussa","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2021.07.104_bib113","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00701-020-04415-5","article-title":"Use of single versus multiple vasodilator agents in the treatment of cerebral vasospasm: is more better than less?","volume":"163","author":"Chen","year":"2021","journal-title":"Acta Neurochir (Wien)"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887502101113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887502101113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:03:48Z","timestamp":1761815028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187887502101113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":113,"alternative-id":["S187887502101113X"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2021.07.104","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Various Therapeutic Agents on Vasospasm and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage\u2013Results of a Network Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2021.07.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}